|Bid||32.19 x 300|
|Ask||32.20 x 900|
|Day's Range||32.09 - 32.44|
|52 Week Range||27.60 - 55.79|
|PE Ratio (TTM)||412.31|
|Dividend & Yield||1.36 (4.15%)|
|1y Target Est||N/A|
A treatment AstraZeneca hoped would replace chemotherapy for some lung cancer patients was no better at preventing the disease from getting worse in clinical tests, dealing a major blow for one of the ...
Philosopher Blaise Pascal never faced proof he was wrong to believe in God. AstraZeneca's Pascal Soriot has discovered his faith in the Mystic cancer drug trial really was misplaced. A failure of a key ...
McCaskill requested that four more drug companies and three drug distributors turn over documents.